PrescriptionGiant is a FREE prescription savings program that can save you up to 75% on your prescriptions with or without insurance!

Delandistrogene moxeparvovec-rokl Injection

Actual product appearance may differ slightly.

Click the CARD below to print or take a screenshot on your mobile phone or tablet. There is no need to download another app!

If you would like to personalize your card enter your full name in the member name field below the card at this link and click the Update button.

Why is this medication prescribed?

Delandistrogene moxeparvovec-rokl Injection, also known as DMR-XI, is a medication prescribed for the treatment of certain genetic disorders, particularly those caused by mutations in the dystrophin gene, such as Duchenne muscular dystrophy (DMD). DMD is a progressive muscle-wasting disease that primarily affects boys and leads to muscle weakness and loss of mobility over time.

DMR-XI is a type of gene therapy that works by delivering a functional copy of the dystrophin gene to the patient’s cells, aiming to compensate for the defective gene responsible for the disorder. By restoring dystrophin expression, DMR-XI intends to slow down the progression of the disease and improve muscle function in affected individuals.

How should this medicine be used?

As for its usage, Delandistrogene moxeparvovec-rokl Injection is typically administered via intravenous infusion. The dosage and frequency of administration are determined by a healthcare professional based on various factors, including the patient’s age, weight, medical history, and the severity of the condition. It’s crucial to follow the specific instructions provided by the healthcare provider regarding the preparation and administration of the injection.

Furthermore, patients undergoing treatment with DMR-XI may require close monitoring for potential side effects and to assess the treatment’s effectiveness over time. Regular follow-up appointments with healthcare providers are essential to ensure optimal management of the condition.

It’s important to note that Delandistrogene moxeparvovec-rokl Injection should only be used under the supervision of qualified healthcare professionals experienced in the treatment of genetic disorders like DMD. As with any medication, it’s essential to discuss any questions or concerns about DMR-XI with your healthcare provider.

Other uses for this medicine

Delandistrogene moxeparvovec-rokl Injection, or DMR-XI, is primarily used for the treatment of genetic disorders caused by mutations in the dystrophin gene, such as Duchenne muscular dystrophy (DMD). However, there may be ongoing research or off-label uses being explored for DMR-XI. Off-label use refers to the use of a medication for a purpose other than what it has been officially approved for by regulatory agencies. These potential uses would need to be investigated further through clinical trials and research studies to establish their safety and efficacy definitively.

What special precautions should I follow?

As for special precautions when using Delandistrogene moxeparvovec-rokl Injection:

  • Administration by Healthcare Professionals: DMR-XI should be administered by qualified healthcare professionals experienced in gene therapy and the management of genetic disorders. They should follow appropriate protocols for preparation, handling, and administration of the injection.
  • Patient Monitoring: Patients receiving DMR-XI should undergo regular monitoring by healthcare providers to assess treatment response, potential side effects, and overall health status. This monitoring may include physical examinations, laboratory tests, and imaging studies.
  • Adverse Reactions: Patients and caregivers should be aware of potential adverse reactions associated with DMR-XI and promptly report any concerning symptoms to healthcare providers. These reactions may include infusion-related reactions, immune reactions, or other adverse effects.
  • Immunosuppression: In some cases, patients receiving gene therapy like DMR-XI may require immunosuppressive therapy to reduce the risk of immune reactions against the therapeutic agent. Healthcare providers will determine if immunosuppression is necessary and monitor patients closely for any associated risks.
  • Genetic Counseling: Before initiating treatment with DMR-XI, patients and their families may benefit from genetic counseling to understand the underlying genetic condition, treatment options, and potential implications for family members.
  • Pregnancy and Breastfeeding: The safety of DMR-XI during pregnancy and breastfeeding has not been established. Healthcare providers should be consulted regarding the potential risks and benefits of treatment in these situations.
  • Storage and Handling: DMR-XI should be stored and handled according to the manufacturer’s instructions to maintain its stability and efficacy.

It’s essential for patients and caregivers to communicate openly with healthcare providers about any questions, concerns, or observations regarding DMR-XI treatment. Additionally, adherence to prescribed treatment regimens and follow-up appointments is crucial for optimizing outcomes and ensuring patient safety.

What special dietary instructions should I follow?

Regarding special dietary instructions, there are typically no specific dietary restrictions associated with Delandistrogene moxeparvovec-rokl Injection. However, it’s essential to maintain a balanced and nutritious diet as advised by healthcare providers to support overall health and well-being.

What should I do if I forget a dose?

If you forget a dose of Delandistrogene moxeparvovec-rokl Injection, contact your healthcare provider immediately for guidance. Depending on the circumstances, they may recommend rescheduling the missed dose or adjusting your treatment plan accordingly. It’s crucial not to double the dose to make up for a missed one without consulting your healthcare provider first. Consistent adherence to the prescribed treatment schedule is essential for maximizing the potential benefits of the medication.

What side effects can this medication cause?

As with any medication, Delandistrogene moxeparvovec-rokl Injection (DMR-XI) can potentially cause side effects. Since DMR-XI is a type of gene therapy, its side effect profile may differ from traditional medications. Common side effects associated with DMR-XI may include:

  • Infusion-related reactions: These reactions may include fever, chills, nausea, vomiting, headache, fatigue, and dizziness during or after the infusion. Healthcare providers typically monitor patients closely during the infusion and may administer medications to manage these symptoms.
  • Immune reactions: In some cases, the body’s immune system may respond to the gene therapy, leading to inflammation or immune-related complications. Symptoms may include swelling, redness, pain, or tenderness at the injection site, as well as systemic immune reactions. Healthcare providers monitor patients for signs of immune reactions and may intervene with appropriate treatments.
  • Laboratory abnormalities: Gene therapy may affect certain laboratory parameters, such as liver enzymes, blood cell counts, and immune function tests. Monitoring these parameters through blood tests helps healthcare providers detect any abnormalities and manage them as needed.
  • Allergic reactions: While rare, allergic reactions to DMR-XI can occur. Symptoms may include rash, itching, swelling of the face or throat, difficulty breathing, or anaphylaxis. Patients should seek immediate medical attention if they experience signs of an allergic reaction.
  • Other adverse effects: Additional side effects reported with gene therapy may include fatigue, muscle pain, joint pain, respiratory symptoms, gastrointestinal symptoms, or neurological symptoms. These side effects vary in severity and may require medical intervention.

It’s important to note that the side effect profile of DMR-XI may evolve as more data is gathered from clinical trials and real-world use. Patients and healthcare providers should remain vigilant for any unexpected or severe side effects and report them to the appropriate authorities as part of ongoing pharmacovigilance efforts. Additionally, patients should discuss any concerns about potential side effects with their healthcare provider before starting treatment with Delandistrogene moxeparvovec-rokl Injection.

What should I know about storage and disposal of this medication?

Storage and disposal of Delandistrogene moxeparvovec-rokl Injection (DMR-XI):

  • Storage: DMR-XI should be stored according to the manufacturer’s instructions, typically in a refrigerator at a controlled temperature. It’s essential to store the medication away from light and moisture and to avoid freezing. Keep DMR-XI out of reach of children and pets.
  • Disposal: Unused or expired DMR-XI should be disposed of properly according to local regulations for hazardous waste or biological materials. Consult your healthcare provider or pharmacist for guidance on safe disposal methods. Do not dispose of DMR-XI in household trash or wastewater.

In case of emergency/overdose

In case of emergency or overdose of Delandistrogene moxeparvovec-rokl Injection, it’s crucial to seek immediate medical attention by contacting your local emergency services or going to the nearest emergency room. Be prepared to provide relevant information about the medication, dosage, and any symptoms experienced. Healthcare professionals will assess the situation and provide appropriate treatment based on the specific circumstances.

What other information should I know?

  • Follow-Up: Regular follow-up appointments with your healthcare provider are essential to monitor treatment response, assess for any side effects or complications, and adjust the treatment plan as needed.
  • Patient Education: Patients and caregivers should receive thorough education about DMR-XI, including its purpose, administration, potential side effects, and signs of complications. Understanding how to recognize and respond to adverse events is crucial for ensuring safe and effective treatment.
  • Genetic Counseling: Consider genetic counseling before starting treatment with DMR-XI to discuss the underlying genetic condition, treatment goals, and potential implications for family members.
  • Clinical Trials: Participation in clinical trials or research studies related to DMR-XI may be available and could offer access to new treatment options or advancements in gene therapy.
  • Adherence: It’s essential to adhere to the prescribed treatment schedule and follow healthcare provider instructions regarding dosage, administration, and monitoring. Missing doses or altering the treatment regimen without medical guidance can affect treatment effectiveness.

By understanding these aspects of storage, disposal, emergency procedures, and additional information, patients and caregivers can ensure the safe and appropriate use of Delandistrogene moxeparvovec-rokl Injection as part of their treatment plan.

Copyright © 2023